Operationalizing Subcutaneous Checkpoint Inhibitors in Practice. Implementing subcutaneous checkpoint inhibitors requires ...
Data from a large prospective study identified male and older patients as being more likely to develop CIP and 34% of cases ...
Long-term NATALEE data show adjuvant ribociclib plus an aromatase inhibitor improves invasive disease–free survival vs AI ...
Chemotherapy-induced myelosuppression (CIM) significantly impacts quality of life for patients with cancer and leads to ...
A preliminary analysis of patient-reported outcomes for emotional functioning (EF) in patients with solid tumors revealed ...
The FDA has granted approval to adjuvant cemiplimab treatment for patients with high-risk cutaneous squamous cell carcinoma ...
On this episode of Onc Nurse On Call, Kristin Daly, MSN, ANP-BC, AOCNP, discusses practical cancer care strategies in the age ...
She emphasized that while elacestrant has properties similar to other agents, imlunestrant is closer to a “pure” ER ...
AI-driven decision support can ease oncologists’ workloads and streamline care without reducing autonomy.
Learn the critical factors in determining prophylaxis for venous thromboembolism, a frequent and serious complication for ...